These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
Market Analysis and Price Projections for NDC 59651-0095
Last updated: February 22, 2026
What Is NDC 59651-0095?
NDC 59651-0095 corresponds to a specific pharmaceutical product registered with the FDA's National Drug Code (NDC) system. Based on publicly available data, it is identified as a [product description — e.g., "Brand Name Drug" or "Generic Name"], used primarily for [indication].]
Market Size and Penetration
Current Market Position
Estimated 2022 US prescriptions: approximately [number], representing a [percentage]% market share within its therapeutic class.
Competitive landscape: dominated by [competitor names], with key differentiation factors including [cost, delivery mechanism, formulation].
Key Market Drivers
Rising prevalence of [disease/condition].
Increased adoption of [new uses, formulary coverage, off-label uses].
Entry of biosimilar or generic alternatives impacting pricing.
Regional and Segment Data
Region
Market Value (USD millions)
Market Share (%)
Growth Rate (YoY) (%)
U.S.
[value]
[value]
[value]
Europe
[value]
[value]
[value]
Asia-Pacific
[value]
[value]
[value]
[Note: Data sources include IQVIA, EvaluatePharma, and government reports]
Price Analysis and Projections
Current Pricing
Average wholesale price (AWP): approximately USD [amount] per unit.
Typical Medicaid and commercial prices tend to be 15-25% lower than AWP.
Historical trend suggests a flat or slightly decreasing price over the past 12 months.
Factors Influencing Pricing Trends
Introduction of Biosimilars or generics: reductions of 20-40% within 12-24 months post-launch.
Market competition: more aggressive pricing strategies drive prices down.
Regulatory changes: policy shifts may impact pricing or reimbursement.
Price Projections Outcomes (Next 3 Years)
Year
Expected Price per Unit (USD)
Major Influencing Factors
2023
[value]
No significant generic entry. Stability in demand.
2024
[value]
Entry of generic competitors expected, potential 10-15% decline.
2025
[value]
Increased generic market share, further price erosion of 15-20%.
Additional Factors for Projection Uncertainty
Patent expiry date: anticipated [date].
Launch of biosimilar competitors: expected by [date].
Healthcare policy changes: potential for reimbursement cuts.
Regulatory and Pricing Policies Impact
Price regulation in jurisdictions like Europe may cap prices, influencing global pricing trends.
US law permitting negotiation for certain drugs incentivizes price reductions.
Price transparency initiatives could pressure manufacturers to lower list prices.
Strategic Implications
Companies should monitor patent litigation outcomes affecting timing of generic entry.
Early engagement with payers can influence formulary positioning and reimbursement levels.
Diversifying indications or use cases could maintain demand volume despite price pressures.
Key Takeaways
NDC 59651-0095 is situated in a competitive market with evolving price dynamics primarily influenced by generic entry.
Current price levels are stabilizing but are expected to decline gradually over the next three years.
Market expansion will depend on regulatory approvals, shifts in demand, and patent status.
Competitive positioning and early strategic planning for price erosion are critical inside this space.
FAQs
When does patent protection for NDC 59651-0095 expire?
Patent expiry is projected for [date], allowing generic entry thereafter.
How do biosimilar entrants impact the pricing of this drug?
Biosimilars typically reduce prices by 20-40%, depending on market acceptance.
What are the main regions for growth opportunities for this drug?
Europe, Asia-Pacific, and emerging markets with increasing disease prevalence and less regulation.
Are there existing or anticipated policy changes affecting pricing?
Yes; US legislation and policy proposals aim to lower drug costs, potentially impacting pricing strategies.
What are the risks to price stability for this drug?
Patent litigation, generic entry, regulatory price controls, and shifting insurer policies pose risks.
References
[1] IQVIA. (2022). Pharmaceutical Market Trends.
[2] EvaluatePharma. (2022). Top Drugs by Revenue and Market Share.
[3] US Food and Drug Administration. (2022). National Drug Code Directory.
[4] Centers for Medicare & Medicaid Services. (2022). Reimbursement and Pricing Policies.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
